We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$26.1B
AUM Growth
+$3.27B
Cap. Flow
+$3.71B
Cap. Flow %
14.22%
Top 10 Hldgs %
13.68%
Holding
2,527
New
200
Increased
1,494
Reduced
642
Closed
151

Sector Composition

Rank Sector Weight
1 Healthcare 9.16%
2 Technology 8.66%
3 Financials 8.59%
4 Industrials 7.31%
5 Consumer Staples 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNSR
2051
DELISTED
Finisar Corp
FNSR
$536K ﹤0.01%
29,979
-34,226
-53% -$727K
PSEC icon
2052
Prospect Capital
PSEC
$1.17B
$535K ﹤0.01%
72,548
+3,062
+4% +$24.6K
KRG icon
2053
Kite Realty
KRG
$5.36B
$533K ﹤0.01%
21,773
-10,229
-32% -$276K
INSY
2054
DELISTED
Insys Therapeutics, Inc.
INSY
$533K ﹤0.01%
14,831
-6,961
-32% -$217K
PPT
2055
Franklin Premier Income Trust
PPT
$328M
$532K ﹤0.01%
104,228
-10,928
-9% -$57.1K
FIW icon
2056
First Trust Water ETF
FIW
$1.94B
$531K ﹤0.01%
16,941
-462
-3% -$14.8K
NTCT icon
2057
NETSCOUT
NTCT
$2.79B
$531K ﹤0.01%
+14,480
New +$594K
WWW icon
2058
Wolverine World Wide
WWW
$1.55B
$531K ﹤0.01%
18,635
+5,895
+46% +$180K
MUA icon
2059
BlackRock MuniAssets Fund
MUA
$522M
$530K ﹤0.01%
39,205
+2,317
+6% +$32.1K
MACK
2060
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$530K ﹤0.01%
5,453
+725
+15% +$69K
NPI
2061
DELISTED
NUVEEN PREMIUN INC MUN FUND
NPI
$530K ﹤0.01%
40,344
+4,673
+13% +$63.1K
RGEN icon
2062
Repligen
RGEN
$9.25B
$528K ﹤0.01%
12,803
+1,088
+9% +$39.9K
TLMR
2063
DELISTED
TALMER BANCORP INC (MI)
TLMR
$524K ﹤0.01%
31,304
+13,394
+75% +$216K
FLC
2064
Flaherty & Crumrine Total Return Fund
FLC
$175M
$523K ﹤0.01%
26,807
-2,000
-7% -$40.9K
WSBC icon
2065
WesBanco
WSBC
$4B
$522K ﹤0.01%
15,341
RBS.PRQ
2066
DELISTED
ROYAL BANK OF SCOTLAND GP PLC (THE) ADR REPSTG PFD SHS SER Q
RBS.PRQ
$522K ﹤0.01%
20,636
CSTM icon
2067
Constellium
CSTM
$3.99B
$521K ﹤0.01%
44,075
-2,846
-6% -$44.7K
CUBE icon
2068
CubeSmart
CUBE
$9.41B
$517K ﹤0.01%
22,330
+1,879
+9% +$44.3K
VKQ icon
2069
Invesco Municipal Trust
VKQ
$551M
$516K ﹤0.01%
42,894
+134
+0.3% +$1.66K
GPM
2070
DELISTED
Guggenheim Enhanced Equity Income Fund
GPM
$514K ﹤0.01%
62,097
-12,970
-17% -$111K
CLM icon
2071
Cornerstone Strategic Value Fund
CLM
$2.25B
$512K ﹤0.01%
24,885
+4,138
+20% +$90.4K
UTG icon
2072
Reaves Utility Income Fund
UTG
$3.61B
$512K ﹤0.01%
18,259
-2,314
-11% -$67.8K
FRO icon
2073
Frontline
FRO
$8.85B
$511K ﹤0.01%
41,845
+620
+2% +$8.28K
GPOR
2074
DELISTED
Gulfport Energy Corp.
GPOR
$511K ﹤0.01%
12,684
-1,235
-9% -$56.6K
FHN icon
2075
First Horizon
FHN
$12.1B
$509K ﹤0.01%
32,495
-1,094
-3% -$16.2K

Similar funds

Raymond James & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Raymond James & Associates held 2,527 positions worth $26.1B, up 14% from $22.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates deployed $3.71B of net new capital in Q2 2015, opening 200 new positions and adding to 1,494 existing holdings. Its largest new stake was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, down from 9.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Williams Companies, an estimated $47.1M trimmed.

  • Raymond James & Associates's largest Q2 2015 buy was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.
  • Raymond James & Associates added most to WisdomTree Europe Hedged Equity Fund in Q2 2015, an estimated $129M increase.
  • Raymond James & Associates's biggest Q2 2015 reduction was Williams Companies, cutting an estimated $47.1M.
  • Raymond James & Associates fully exited Allergan plc in Q2 2015, selling an estimated $76M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2015.
  • Raymond James & Associates opened 200 new positions and closed 151 in Q2 2015.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $26.1B.

Based on Raymond James & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.